Login / Signup

Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.

Li Shen LooJessica AilaniJack SchimSimin BayganiHans-Peter HundemerMartha D PortJohn H Krege
Published in: The journal of headache and pain (2019)
SAMURAI (NCT02439320) and SPARTAN (NCT02605174). Registered 18 March 2015.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • open label
  • double blind
  • clinical trial
  • patient reported outcomes